Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma of Skin Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05039801
What this trial is testing

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Looking for participantsNCT05026983
What this trial is testing

Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic MelanomaPathologic Stage IV Cutaneous Melanoma AJCC v8
M.D. Anderson Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT00085189
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeExtraocular Extension Melanoma+14 more
University of Southern California 42
Testing effectiveness (Phase 2)Study completedNCT01480323
What this trial is testing

A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 15
Testing effectiveness (Phase 2)Looking for participantsNCT05361174
What this trial is testing

Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Who this might be right for
Unresectable MelanomaMetastatic MelanomaStage III Non-small Cell Lung Cancer+1 more
Iovance Biotherapeutics, Inc. 53
Early research (Phase 1)Looking for participantsNCT06946225
What this trial is testing

ACTengine® IMA203 Combined With mRNA-4203

Who this might be right for
Cutaneous MelanomaSynovial Sarcoma
Immatics US, Inc. 15
Testing effectiveness (Phase 2)WithdrawnNCT02143050
What this trial is testing

Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients

Who this might be right for
Melanoma
University of Louisville
Early research (Phase 1)UnknownNCT03086174
What this trial is testing

Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma

Who this might be right for
Kidney Cancer Stage IvAdvanced Melanoma
Shanghai Junshi Bioscience Co., Ltd. 24
Early research (Phase 1)Study completedNCT02166255
What this trial is testing

APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more
Wake Forest University Health Sciences 17
Early research (Phase 1)Study completedNCT02659540
What this trial is testing

Pilot Study of the Safety/Efficacy of Combination Checkpoint Blockade + External Beam Radiotherapy in Stage IV Melanoma

Who this might be right for
Melanoma
Ludwig Institute for Cancer Research 20
Early research (Phase 1)Study completedNCT00729950
What this trial is testing

Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

Who this might be right for
Malignant Melanoma
Bristol-Myers Squibb 92
Testing effectiveness (Phase 2)Looking for participantsNCT05296564
What this trial is testing

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

Who this might be right for
Sarcoma, SynovialSarcoma,Soft TissueMelanoma Stage IV+6 more
Hadassah Medical Organization 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05180799
What this trial is testing

BA3071 in Patients With Solid Tumors

Who this might be right for
NSCLCMelanoma
BioAtla, Inc. 320
Early research (Phase 1)Active Not RecruitingNCT03816332
What this trial is testing

Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+18 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00036764
What this trial is testing

BMS-247550 in Treating Patients With Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 88
Testing effectiveness (Phase 2)Study completedNCT00568048
What this trial is testing

Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Melanoma (Skin)
Swiss Cancer Institute 62
Testing effectiveness (Phase 2)UnknownNCT01676649
What this trial is testing

Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma

Who this might be right for
Untreated Stage III Melanoma or Stage IV Melanoma
Jewish General Hospital 30
Early research (Phase 1)Study completedNCT00390338
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Pawel Kalinski 22
Early research (Phase 1)WithdrawnNCT00006126
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery

Who this might be right for
Breast CancerKidney CancerLung Cancer+2 more
Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT01166126
What this trial is testing

Temsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IV

Who this might be right for
Mucosal MelanomaRecurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 4
Next Page